🇺🇸 FDA
Patent

US 10582702

Non-human animals having an engineered ANGPTL8 gene

granted A61KA61K2039/505A61K49/0008

Quick answer

US patent 10582702 (Non-human animals having an engineered ANGPTL8 gene) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K49/0008